According to the latest report by IMARC Group, titled “Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” The global genomics market reached a value of US$ 25.11 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.26 Billion by 2027, exhibiting a CAGR of 15.54% during 2022-2027.
Request Free Sample Report: https://www.imarcgroup.com/genomics-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Breakup by Component:
- Instruments and Software
- Consumables and Reagents
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
Consumables and reagents hold the biggest market share as they aid in performing single-molecule and real-time (SMRT) sequencing.
Breakup by Application:
- Functional Genomics
- Biomarkers Discovery
- Pathway Analysis
Functional genomics dominates the application segment as they help improve crop plants, human health, and livestock.
Breakup by Technology:
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
Sequencing exhibits a clear dominance in the market as it provides information on genetic variants that can lead to different diseases.
Breakup by End-User:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
Pharmaceutical and biotechnology companies hold the majority of the total market share as they help modify genes and provide a new platform for the high-throughput genetic analysis of forest trees.
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
- 23andMe, Inc
- Agilent Technologies, Inc
- Bayer AG
- BGI Group
- Bio-Rad Laboratories, Inc
- Danaher Corporation
- Illumina, Inc
- Oxford Nanopore Technologies
- PerkinElmer, Inc
- Myriad Genetics, Inc
- Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://bit.ly/3UJK1WF
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800